维普期刊资源整合服务平台（V6.5）

169篇 您的检索式：作者名="Kantoff"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer:Results of the cancer and leukemia group B 9182 study显示文摘	Kantoff PW Halabi S Conaway M	1999	J Clin Oncol1999，17，8：	1
2	Modification of BRCA1 - associated breast cancer risk by the polymorphic androgenreceptor CAG repeat显示文摘	TR Kantoff PW Krithivas K	1999	Am J Hum Genet1999，64，5：	1
3	Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer:results of the cancer and leukemia group B 9182 study显示文摘	Kantoff PW Halabi S Conaway M	1999	J Clin Oncol1999，17，：	1
4	Sipuleucel-T immunotherapy for castration resistant prostate cancer显示文摘	KANTOFF P W HIGANO C S SHORE N D	2010	N Engl J Med2010，363，5：	1
5	Sipuleu- cel-T immune parameters correlate with survival: an a- nalysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer 显示文摘	Sheikh N A Petrylak D Kantoff P W	2013	Cancer Im- munol Immunother2013，62，1：	1
6	Immunotherapy for the treatment of prostate cancer显示文摘	Di LG Buonerba C Kantoff PW	2011	Nat Rev Clin Oncol2011，8，9：	1
7	Sipuleucel- T immunotherapy for castration-resistant prostate cancer 显示文摘	Kantoff P W Higano C S Shore N D	2010	N Engl J Med2010，363，4：	1
8	Management of hormone refractory p rostate cancer: current standards and future prospects 显示文摘	OH WK Kantoff PW	1998	J Urol1998，160，4：	1
9	O- verall survival analysis of a phase II randomized con- trolled trial of a Poxviral-based PSA-targeted immuno-therapy in metastatic castration-resistant prostate cancer 显示文摘	Kantoff P W Schuetz T J Blumenstein B A	2010	J Clin Oncol2010，28，7：	1
10	Integration of immunotherapy into the man- agement of advanced prostate cancer显示文摘	Kantoff P Higano CS	2012	UrolOncol2012，30，5：	1
11	Sipuleueel -T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration - resistant prostate cancer显示文摘	Sheikh NA Petrylak D Kantoff PW	2013	Cancer lmmunol Immunother2013，62，1：	1
12	Managemet of hormone refractory prostate cancer:current standard and future prospects 显示文摘	Oh W K Kantoff P W	1998	J Urol1998，160，：	1
13	Overall survival analysis of a phase Ⅱ randomized controlled trial of Poxviral -based PSA -targeted imnmnotherapy in metastatic castration-resistant prostate cancer 显示文摘	Kantoff PW Schuetz TJ Blumenstein BA	2010	J Clin Oncol2010，28，7：	1
14	Sipuleucel - T immuno- therapy for castration -resistant prostate cancer显示文摘	Kantoff P W Higano C S Shore N D	2010	N Engl J Med2010，363，5：	1
15	Sipuleucel-T immu- notherapy for castration - resistant prostate cancer 显示文摘	Kantoff PW Higano CS Shore ND	2010	N Engl J Med2010，363，5：	1
16	Sipuleucel-T im- munotherapy for castration resistant prostate cancer 显示文摘	KANTOFF P W HIGANO C S SHORE N D	2010	N Engl J Med2010，363，4：	1
17	Sipuleucel-T im- munotherapy for castration-resistant prostate cancer显示文摘	Kantoff PW Higano CS Shore ND	2010	N Engl J Med2010，363，5：	1
18	Sipuleucel-T immuno therapy for castration-resistant prostate cancer 显示文摘	Kantoff PW Higano CS Shore ND	2010	N Engl J Med2010，363，5：	1
19	Sipuleucel-T immunotherapy for castration-resistant prostate cancer显示文摘	Kantoff PW Higano CS Shore ND	2010	N Engl J Med2010，363，5：	1
20	Management of hormone refractory prostate cancer:current standards and future prospects显示文摘	Kantoff PW	1998	J Urol1998，160，：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示